Icon plc
Irish clinical research organization company
ICLR Nasdaq
ISIN IE0005711209 SEC CIK 1060955
Follow Icon
Weekly email: filings, results
Revenue, last quarter
$2B
−2.9% vs same quarter last year
Net income
$122.1M
+143% vs same quarter last year
EPS, diluted
$1.58
+143.1% vs same quarter last year
Operating cash flow
$345.1M
−11% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $8.3B | $229.3M |
| FY24 | $8.2B | $739.1M |
| FY23 | $8.1B | $554.2M |
| FY22 | $7.7B | $505.3M |
| FY21 | $5.5B | $153.2M |
| FY20 | $2.8B | $332.3M |
| FY19 | $2.8B | $374M |
| FY18 | $2.6B | $322.7M |
| FY17 | $1.8B | $281.5M |
| FY16 | $1.7B | $262.2M |
| FY15 | $1.6B | $239.5M |
| FY14 | $1.5B | $172.5M |
| FY13 | $1.3B | $102.8M |
| FY12 | $1.1B | $55.4M |
| FY11 | $945.7M | $22.9M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | 5.4% | 2.8% |
| FY24 | 28.6% | 12.6% | 9% |
| FY23 | 29% | 11.2% | 6.9% |
| FY22 | 28.6% | 10.3% | 6.5% |
| FY21 | 27.5% | 6.9% | 2.8% |
| FY20 | 29.2% | 14% | 11.9% |
| FY19 | 29.6% | 15.4% | 13.3% |
| FY18 | 30% | 14.4% | 12.4% |
| FY17 | 41.6% | 19.2% | 16% |
| FY16 | 42.3% | 18.7% | 15.7% |
| FY15 | 42.3% | 17.9% | 15.2% |
| FY14 | 39.9% | 13.5% | 11.5% |
| FY13 | 36.7% | 9.1% | 7.7% |
| FY12 | 35.6% | 6.1% | 5% |
| FY11 | 35.3% | 3.1% | 2.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $862M |
| FY24 | $1.1B |
| FY23 | $1B |
| FY22 | $421.2M |
| FY21 | $735.4M |
| FY20 | $527.2M |
| FY19 | $373.6M |
| FY18 | $220.2M |
| FY17 | $338.4M |
| FY16 | $216.6M |
| FY15 | $229.3M |
| FY14 | $137.2M |
| FY13 | $191.7M |
| FY12 | $82.6M |
| FY11 | −$15.1M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $750M |
| FY24 | $500M |
| FY23 | $0 |
| FY22 | $100M |
| FY21 | $0 |
| FY20 | $175M |
| FY19 | $146.9M |
| FY18 | $129M |
| FY17 | $133.1M |
| FY16 | $110M |
| FY15 | $457.9M |
| FY14 | $140M |
| FY13 | - |
| FY12 | $15.6M |
| FY11 | $9M |
- Icon
- Healthcare median
Show the numbers
| Year | Icon | Healthcare median |
|---|---|---|
| FY25 | 2.8% | −30.6% |
| FY24 | 9% | −47% |
| FY23 | 6.9% | −58% |
| FY22 | 6.5% | −80.4% |
| FY21 | 2.8% | −71.9% |
| FY20 | 11.9% | −62.2% |
| FY19 | 13.3% | −46.3% |
| FY18 | 12.4% | −49.6% |
| FY17 | 16% | −45.9% |
| FY16 | 15.7% | −36% |
| FY15 | 15.2% | −38.4% |
| FY14 | 11.5% | −35.5% |
| FY13 | 7.7% | −37.1% |
| FY12 | 5% | −29.1% |
| FY11 | 2.4% | −27.9% |